Guggenheim Investments Declares Monthly and Year-End Fixed

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Guggenheim Investments Declares Monthly and Year-End Fixed Income ETF Distributions for 2015

NEW YORK, Dec. 28, 2015 (GLOBE NEWSWIRE) -- Guggenheim Investments, the investment management division of Guggenheim Partners, announced today that its fixed income exchange traded funds (ETFs) (the “Funds”), including the Guggenheim BulletShares Corporate Bond ETFs (the “Guggenheim BulletShares ETFs”), have declared regular monthly and year-end distributions.

For more information on year-end distributions related to Guggenheim Investments ETFs, please visit http://guggenheiminvestments.com/products/etf...tributions or call the Guggenheim ETF Knowledge Center at 888.WHY ETFS.

Past performance is not indicative of future performance. To the extent any portion of the distribution is estimated to be sourced from something other than income, such as return of capital, the source would be disclosed on a Section 19(a)-1 letter located on the Fund’s website under the “Literature” tab. Distributions may be comprised of sources other than income, which may not reflect actual fund performance. For more information, please visit http://www.guggenheiminvestments.com/products/etf .

About Guggenheim Investments  Guggenheim Investments is the global asset management and investment advisory division of Guggenheim Partners, with $199 billion 1 in assets across fixed income, equity, and alternative strategies. We focus on the return and risk needs of insurance companies, corporate and public pension funds, sovereign wealth funds, endowments and foundations, wealth managers, and high-net-worth investors. Our 275+ investment professionals perform rigorous research to understand market trends and identify undervalued opportunities in areas that are often complex and underfollowed. This approach to investment management has enabled us to deliver innovative strategies providing diversification opportunities and attractive long-term results.

1 Guggenheim Investments total asset figure is as of 09.30.2015. The assets include leverage of $11.8bn for assets under management and $0.5bn for assets for which we provide administrative services. Guggenheim Investments represents the following affiliated investment management businesses: Guggenheim Partners Investment Management, LLC, Security Investors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Funds Distributors, LLC, Guggenheim Real Estate, LLC, Transparent Value Advisors, LLC, GS GAMMA Advisors, LLC, Guggenheim Partners Europe Limited, and Guggenheim Partners India Management.

Read a fund’s prospectus and summary prospectus (if available) carefully before investing. It contains the fund’s investment objectives, risks, charges, expenses and other information, which should be considered carefully before investing. Obtain a prospectus and summary prospectus (if available) at http://guggenheiminvestments.com/home or call 800.820.0888.

The referenced funds are distributed by Guggenheim Funds Distributors, LLC. Guggenheim Investments represents the investment management businesses of Guggenheim Partners, LLC (“Guggenheim”), which includes Guggenheim Funds Investment Advisors, LLC ("GFIA") and Guggenheim Partners Investment Management (“GPIM”), the investment advisors to the referenced funds. Guggenheim Funds Distributors, LLC, is affiliated with Guggenheim, GFIA and GPIM.

 

Media Contact Ivy McLemore Director of Intermediary Communications Guggenheim Investments Ivy.mclemore@guggenheimpartners.com (212) 518-9859

Scroll down for more posts ▼

Top 10 Most Recent News Articles

OppFi Readies Q3 Earnings; Investors Eye Financials

Updated Category News Views 8

What's Unfolding at OppFi? Mark your calendars, folks. October 28th is the day OppFi (NYSE: OPFI) pulls the curtain back on its third-quarter 2026 earnings. For the uninitiated, we're talking about a tech-driven finance platform that's been making waves by providing financial solutions for everyday Americans. And you bet we're all ears for what those numbers say. Details...

Continue Reading
Purlin's Patent: Transforming Real Estate Deals

Updated Category News Views 1

Purlin's Game-Changer: A Patent in Real Estate Real estate has been chugging along like a stubborn mule, dragging deals through opaque negotiations and haphazard guessing games. Then enters Final Offer from Purlin Enterprises, waving a newly granted patent like a shiny golden ticket to those stuck trading homes in the dark. Leveling the Playing Field with Transparency In...

Continue Reading
Mastering Power Efficiency with Phase Converters

Updated Category News Views 1

Powering Multiple Machines: A New Approach? You ever look at a workshop crammed with machines and wonder if it's all a waste of space, time, and money? Jay Yuergens from North America Phase Converter Co. gives us the lowdown on how one rotary or digital phase converter can handle the load. And let me tell you, it ain't as crazy as it sounds. It's all about finesse and...

Continue Reading
Cruise Planners Sets AI Benchmark in Travel Innovs

Updated Category News Views 11

Unveiling the AI Arsenal of Cruise Planners Alright, listen up, folks. When you think about travel and tech, Cruise Planners ain't just dipping a toe—they're cannonballing right in, splashing everyone around with their shiny new AI tricks. Twenty-three. That's how many innovations they're flaunting this year. It's like they're running a tech marathon, and boy, are they...

Continue Reading
De¹ Unveils Tokenization Model on BNB Chain

Updated Category News Views 15

De¹'s Bold Move into Enhanced Digital Finance Just when you thought the financial landscape couldn’t get any more complex, De¹ steps into the ring with its Tokenized Asset World on the BNB Chain—a move that's stirring the pot of tokenized finance in more ways than one. For old-school investors who thrive on waving outlandish stock bets, this crypto narrative is a...

Continue Reading
Flotek Faces Class Action as PREPA Contract Dissolves

Updated Category News Views 0

Flotek's 10-Year Project Shattered by Canceled Agreement Here's a brew you won't find down at any greasy spoon: Flotek Industries (NYSE: FTK) finds itself tangled in a legal web after their highly touted project in Puerto Rico went belly-up. That's one heck of a slice off their revenue pie, and investors best have their radar turned on. The lawsuit's all about what's...

Continue Reading
Workday Hits High Note in 2026 Gartner Magic Quadrant

Updated Category News Views 14

Workday Secures Leadership Position In a wild ride that's left investors with whiplash in recent years, Workday (NASDAQ: WDAY) has firmly planted its flag at the top tier of the 2026 Gartner® Magic Quadrant™ for Cloud ERP Finance. This announcement out of Pleasanton, California, resonates like a victory bell for the company's finance management solutions—a mix of AI,...

Continue Reading
Ball Corp's Leadership Shuffle Aims for Strategic Gains

Updated Category News Views 9

Leadership Changes in the Midst of Market Challenges You don't need a crystal ball to see that leadership changes can signal either turmoil or opportunity. Ball Corporation, a titan in the realm of aluminum packaging, is experiencing a shake-up at the top of its beverage packaging business units. With Carey Causey stepping into the role for North and Central America, and...

Continue Reading
Standex's New Financial Lead: Stoddard Takes Helm

Updated Category News Views 9

New Financial Captain Aboard Standex's Ship Alright, here's something that'll have investors nodding along with interest: Standex International has just named Samantha L. Stoddard as their incoming Chief Financial Officer and Treasurer, effective December 1, 2026. Now, Standex isn't some scrappy upstart. We're talking about a veteran manufacturer intricately working...

Continue Reading
Florida Cancer Center Expands Expertise with New Oncologist

Updated Category News Views 11

Welcoming a Highly Skilled Oncologist to Fort Myers There's an old saying in the world of investing: follow the expertise. And when it comes to healthcare, especially cancer treatment, expertise can make a world of difference. Florida Cancer Specialists & Research Institute (FCS) is throwing its hat in the ring with authority, as they welcome Dr. Kelly Elleson, a surgical...

Continue Reading

Top 5 Most Recently Viewed Articles

Job Market Insights: Anticipation Builds as Reports Loom

Updated Category News Views 239

Overview of Upcoming Job Reports As the job market continues to be a significant focus for investors and economists alike, there is growing anticipation surrounding a crucial jobs report from the Bureau of Labor Statistics. Scheduled for release on Friday morning, this report is expected to shape economic forecasts and market reactions. What to Expect from the Jobs Report...

Continue Reading
Enterprise Financial Services Corp Announces Q4 Earnings Call Details

Updated Category News Views 96

Join the Upcoming Conference Call for Q4 2024 Earnings Enterprise Financial Services Corp (Nasdaq: EFSC) is set to announce its financial results for the fourth quarter of 2024. This eagerly anticipated release is scheduled for the final days of January. Finance enthusiasts and stakeholders are encouraged to tune into the conference call and webcast where they can gain...

Continue Reading
Wearable Devices Secures $4 Million in Innovative Funding

Updated Category News Views 224

Wearable Devices Announces Successful Funding Initiative Yokneam Illit, Israel – In a significant milestone, Wearable Devices Ltd. (NASDAQ: WLDS, WLDSW), renowned for their groundbreaking artificial intelligence (AI) technology that powers touchless sensing wearables, has successfully initiated a securities purchase agreement. This agreement involves the sale of 670,000...

Continue Reading
Potential Growth for First Solar Stocks Amid Declining Price

Updated Category News Views 122

Firm Outlook as First Solar Prepares for Earnings Report First Solar Inc (NASDAQ: FSLR) is preparing to reveal its fourth-quarter earnings. Analysts predict earnings per share (EPS) to come in at $4.71, while overall revenues are expected to reach $1.47 billion. These figures are set to be announced after market hours, creating significant anticipation among investors....

Continue Reading
Candel Therapeutics Reports Promising Results for Cancer Treatment

Updated Category News Views 246

Candel Therapeutics Publishes Clinical Trial Findings In an exciting development for cancer treatment, Candel Therapeutics, Inc. (Nasdaq: CADL), a clinical stage biopharmaceutical company specializing in innovative immunotherapies, has announced the publication of their phase 1b clinical trial results. This landmark study investigated the safety and tolerability of...

Continue Reading